Additive effects of intensive BP control and ACE inhibition on suppression of proteinuria in patients with CKD

The synergistic effects of RAAS inhibition and intensive blood pressure lowering in reducing proteinuria have not been well studied. We aimed to study this effect using data from the AASK Trial where our data suggest there is an additive and synergistic effect between RAAS inhibition and intensive blood pressure inhibition in reducing proteinuria.

Automated summary

This study analyzes data from the AASK Trial and finds that there is an additive and synergistic effect between RAAS inhibition and intensive blood pressure lowering in reducing proteinuria.